Evidence map›Paper›PMID 39346283›Full record

ArticleJournal of pharmacy & bioallied sciences2024

Inflammatory Myofibroblastic Tumor of the Urinary Bladder of a Young Female: A Case Report on Diagnosis and Management Challenges.

Sulaiman Almutairi

Abstract readCase Reports
In one paragraph

Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Sulaiman AlmutairiDepartment of Urology, College of Medicine, Majmaah University, Al-Majmaah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory myofibroblastic tumor (IMT) is a rare tumor with intermediate biologic potential, in which lack of understanding often poses difficulties in preoperative diagnosis and management. We report a case in which a 25-year-old female patient not known to have any medical illness presented with gross hematuria for one month. The patient was investigated with urine analysis, urine culture, urine cytology, and Ct-Urogram at a urology clinic. Her investigation showed a urinary bladder dome enhancing mass 3.6 * 3.8 * 3.3 cm with minimal surrounding perivesical stranding worrisome for early peritoneal carcinomatosis. She underwent cystoscopy and transurethral bladder tumor resection; resection was not complete due to the size of bladder mass. Six units of packed red blood cells were given. Histopathology showed IMT. Case was discussed in the tumor board and the patient underwent laparoscopic urachal resection and partial cystectomy. Discharged on day three post-op with Foley catheter and appointment for cystogram after 2 weeks. Histopathology confirms the diagnosis of IMT with four millimeters of free margin and two benign regional reactive lymph nodes. Patients were followed for two years with no sign of recurrence or any lower urinary tract symptoms. Our report reinforces the standard diagnostic and management approach, supporting consistent findings and successful surgical strategies, to enhance patient care and understanding of this rare neoplasm.

Indexed as

Benign bladder tumorhematuriainflammatory myofibroblastic tumorurachal mass

Identifiers

PMID39346283
PMCPMC11426765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.